BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 19802803)

  • 1. [Renal involvement in Fabry's disease: diagnosis, follow-up and enzyme replacement therapy].
    Mignani R; Feriozzi S; Carraro G; Martinelli F; Cianciaruso B
    G Ital Nefrol; 2009; 26(5):577-84. PubMed ID: 19802803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.
    Mignani R; Feriozzi S; Schaefer RM; Breunig F; Oliveira JP; Ruggenenti P; Sunder-Plassmann G
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):379-85. PubMed ID: 20056752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enzyme replacement therapy in Fabry's disease].
    Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
    Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal lesions in patients with Fabry's disease].
    Gubler MC
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S220-5. PubMed ID: 21211668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fabry's disease; towards a treatment].
    Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
    Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
    Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular outcomes in Fabry disease are linked to severity of chronic kidney disease.
    Talbot AS; Lewis NT; Nicholls KM
    Heart; 2015 Feb; 101(4):287-93. PubMed ID: 25381325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy and Fabry nephropathy.
    Warnock DG; Daina E; Remuzzi G; West M
    Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
    Mignani R; Cagnoli L
    J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients].
    Cianciaruso B; Pisani A; Andreucci MV; Parente N; Andria G; Federico S; Sabbatini M; Sessa A
    G Ital Nefrol; 2003; 20(2):113-9. PubMed ID: 12746795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
    Mahmud HM
    J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
    Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
    Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fabry's disease (alpha-galactosidase-A deficiency): recent therapeutic innovations].
    Germain DP
    J Soc Biol; 2002; 196(2):183-90. PubMed ID: 12360747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of Fabry's disease with chronic renal failure].
    Suzuki T; Fujino T; Sugasawa M; Kohara Y; Toyama K; Sato T; Yasuda T; Sugiyama M; Maeba T; Owada S; Ishida M
    Nihon Jinzo Gakkai Shi; 1999 Jun; 41(4):448-53. PubMed ID: 10441995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy of replacement enzyme therapy on central nervous system manifestations in Fabry's disease].
    Besson G; Vadot W; Guellerin J
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S257-9. PubMed ID: 21211675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ocular findings in Fabry's disease].
    Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
    Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fabry disease: demographic data since introduction of enzyme replacement therapy].
    Cybulla M; Walter K; Neumann HP; Widmer U; Schärer M; Sunder-Plassmann G; Jansen T; Rolfs A; Beck M
    Dtsch Med Wochenschr; 2007 Jul; 132(28-29):1505-9. PubMed ID: 17607649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electron microscopy in end stage renal disease: a case of Fabry's disease.
    Doldan-Silvero AM; Nunnemacher G; Germain M; Crisi GM
    Ultrastruct Pathol; 2010 Oct; 34(5):307-13. PubMed ID: 20929308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fabry's disease. Light and electron microscopic cardiac findings 12 years after successful kidney transplantation].
    Bannwart F
    Schweiz Med Wochenschr; 1982 Nov; 112(48):1742-7. PubMed ID: 6294821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's disease].
    Thomaidis T; Relle M; Reinke J; Beck M; Schwarting A
    Med Klin (Munich); 2009 Sep; 104(9):699-703. PubMed ID: 19779674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.